PAMP
NAUT icon

Polar Asset Management Partners’s Nautilus Biotechnolgy NAUT Stock Holding History

Polar Asset Management Partners’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-150,000
Closed -$1.62M – 862
2020
Q3 		$1.62M Buy
+150,000
New +$1.6M 0.02% 266

Other funds holding NAUT

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Polar Asset Management Partners's NAUT Position: Q4 2020 in Review

Polar Asset Management Partners sold out of Nautilus Biotechnolgy (NAUT) in Q4 2020, closing a stake of 150,000 shares — an estimated $1.62M sold.

Polar Asset Management Partners first reported a position in NAUT in Q3 2020 and held it in 1 quarter. The position peaked at $1.62M in Q3 2020. 43 funds tracked by Wall St. Rank hold NAUT as of Q4 2020.

  • Polar Asset Management Partners reported no remaining Nautilus Biotechnolgy position as of Q4 2020 after selling out during the quarter.
  • Polar Asset Management Partners sold 150,000 Nautilus Biotechnolgy shares in Q4 2020, an estimated $1.62M.
  • Polar Asset Management Partners first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 1 quarter.
  • Polar Asset Management Partners's Nautilus Biotechnolgy position peaked at $1.62M in Q3 2020.
  • 43 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2020.

Based on Polar Asset Management Partners's 13F filing for Q4 2020, filed 16 Feb 2021.